PROCEPT BioRobotics® (Nasdaq: PRCT) today highlighted the latest update to the American Urological Association (AUA) Guidelines for the management of lower urinary tract symptoms (LUTS) attributed to ...
For 69-year-old Andre Price, living with an enlarged prostate was affecting every part of his life. "I was getting up every hour and a half," Price says of having to wake frequently to use the ...
CHI Memorial announces it is the first in the Chattanooga region to offer Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), or ...
Two interventions to treat large prostates produced similar symptom relief but had different effects on prostate volume and different adverse event profiles, a large randomized trial showed. Baseline ...
THOMASVILLE — Archbold is now offering Aquablation therapy with the new HYDROS™ Robotic System, the next-generation platform to treat men suffering from benign prostatic hyperplasia (BPH). BPH, ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
WATERBURY, Conn. (WTNH) — Benign prostatic hyperplasia, or an enlarged prostate, can change the lives of most men as they age. Connecticut pediatrician recommends back to school vaccinations In the ...
A new treatment for an enlarged prostate is gaining popularity among doctors in Southwest Florida. The innovative procedure offers relief without traditional surgery. James Crumbaugh, a patient who ...
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company”), a surgical robotics company dedicated to advancing patient care through ...
Scottsdale, Ariz.-based East Valley Urology has completed the first three prostate cancer procedures in PROCEPT BioRobotics’ FDA-approved WATER IV trial using Aquablation therapy. The outpatient ...
SAN ANTONIO — "Aquablation," an investigational nonthermal and robotically assisted means of treating benign prostatic hypertrophy (BPH) using a waterjet, has shown advantages over transurethral ...